Matthew Rabinowitz Ph.D.
Net Worth

Last updated:

What is Matthew Rabinowitz Ph.D. net worth?

The estimated net worth of Dr. Matthew Rabinowitz Ph.D. is at least $502,965,035 as of 13 Dec 2024. He owns shares worth $382,412,151 as insider, has earned $115,410,284 from insider trading and has received compensation worth at least $5,142,600 in Natera, Inc..

What is the salary of Matthew Rabinowitz Ph.D.?

Dr. Matthew Rabinowitz Ph.D. salary is $514,260 per year as Co-Founder & Executive Chairman in Natera, Inc..

How old is Matthew Rabinowitz Ph.D.?

Dr. Matthew Rabinowitz Ph.D. is 52 years old, born in 1973.

What stocks does Matthew Rabinowitz Ph.D. currently own?

As insider, Dr. Matthew Rabinowitz Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Natera, Inc. (NTRA) Co-Founder & Executive Chairman 2,389,180 $160.06 $382,412,151

What does Natera, Inc. do?

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum to identify chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle. The company also provides Anora miscarriage test products to analyze fetal chromosomes to understand the cause of miscarriage; and non-invasive paternity testing products to determine paternity by gestation using a blood draw from the pregnant mother and alleged father. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics in order to validate and launch tests; Signatera, a circulating tumor DNA technology that screen for a generic set of mutations independent of an individual's tumor; and Prospera used to assess organ transplant rejection. The company offers products through its direct sales force, as well as through a network of approximately 100 laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was formerly known as Gene Security Network, Inc. and changed its name to Natera, Inc. in 2012. Natera, Inc. was founded in 2003 and is based in Austin, Texas.

Matthew Rabinowitz Ph.D. insider trading

Natera, Inc.

Dr. Matthew Rabinowitz Ph.D. has made 79 insider trades between 2015-2024, according to the Form 4 filled with the SEC. Most recently he sold 5,300 units of NTRA stock worth $892,282 on 13 Dec 2024.

The largest trade he's ever made was exercising 732,831 units of NTRA stock on 19 Jun 2016. As of 13 Dec 2024 he still owns at least 2,389,180 units of NTRA stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 5,300 $168.36 $892,282
Sale
Common Stock 28,681 $164.61 $4,721,208
Sale
Common Stock 75,323 $165.45 $12,462,190
Sale
Common Stock 4,927 $167.39 $824,721
Sale
Common Stock 45,769 $166.45 $7,618,342
Option
Common Stock 68,496 $5.4 $369,536
Option
Stock Option (right to buy) 68,496 $5.4 $369,536
Sale
Common Stock 400 $165.55 $66,220
Sale
Common Stock 940 $164.24 $154,384
Sale
Common Stock 660 $163.25 $107,744
Sale
Common Stock 600 $168.91 $101,346
Sale
Common Stock 1,089 $167.89 $182,831
Sale
Common Stock 311 $169.94 $52,851
Option
Stock Option (right to buy) 10,000 $5.4 $53,950
Option
Common Stock 10,000 $5.4 $53,950
Option
Stock Option (right to buy) 130,000 $5.4 $701,350
Option
Common Stock 130,000 $5.4 $701,350
Option
Common Stock 215,000 $5.4 $1,159,925
Option
Stock Option (right to buy) 215,000 $5.4 $1,159,925
Sale
Common Stock 120 $56.08 $6,730
Option
Common Stock 401 N/A N/A
Option
Restricted Stock Unit 401 N/A N/A
Sale
Common Stock 2,484 $56.32 $139,904
Sale
Common Stock 2,706 $39.55 $107,030
Option
Common Stock 6,763 N/A N/A
Option
Restricted Stock Unit 6,763 N/A N/A
Option
Common Stock 400 N/A N/A
Option
Restricted Stock Unit 400 N/A N/A
Option
Restricted Stock Unit 400 N/A N/A
Option
Common Stock 400 N/A N/A
Option
Common Stock 400 N/A N/A
Option
Restricted Stock Unit 400 N/A N/A
Purchase
Common Stock 19,011 $29.57 $562,060
Purchase
Common Stock 159,783 $28.81 $4,603,348
Purchase
Common Stock 41,026 $28.09 $1,152,379
Option
Restricted Stock Unit 307 N/A N/A
Option
Common Stock 307 N/A N/A
Option
Restricted Stock Unit 401 N/A N/A
Option
Common Stock 401 N/A N/A
Option
Stock Option (right to buy) 160,000 $2.66 $425,120
Option
Common Stock 160,000 $2.66 $425,120
Option
Restricted Stock Unit 2,819 N/A N/A
Option
Common Stock 90,000 $2.66 $239,130
Option
Common Stock 2,819 N/A N/A
Option
Stock Option (right to buy) 90,000 $2.66 $239,130
Option
Common Stock 307 N/A N/A
Option
Restricted Stock Unit 307 N/A N/A
Option
Common Stock 400 N/A N/A
Option
Restricted Stock Unit 400 N/A N/A
Option
Restricted Stock Unit 2,818 N/A N/A
Option
Common Stock 2,818 N/A N/A
Sale
Common Stock 122 $112.19 $13,687
Option
Restricted Stock Unit 307 N/A N/A
Option
Common Stock 307 N/A N/A
Option
Restricted Stock Unit 400 N/A N/A
Sale
Common Stock 159 $125.67 $19,982
Option
Common Stock 400 N/A N/A
Sale
Restricted Stock Unit 876 N/A N/A
Sale
Common Stock 2,818 N/A N/A
Sale
Common Stock 76 N/A N/A
Option
Common Stock 307 N/A N/A
Option
Restricted Stock Unit 307 N/A N/A
Sale
Common Stock 99 N/A N/A
Option
Common Stock 400 N/A N/A
Option
Restricted Stock Unit 400 N/A N/A
Sale
Common Stock 698 $102.6 $71,617
Option
Common Stock 2,818 N/A N/A
Option
Restricted Stock Units 2,818 N/A N/A
Sale
Common Stock 76 N/A N/A
Option
Common Stock 307 N/A N/A
Option
Restricted Stock Units 307 N/A N/A
Sale
Common Stock 101 $101.72 $10,274
Option
Common Stock 401 N/A N/A
Option
Restricted Stock Units 401 N/A N/A
Sale
Common Stock 766 $97.31 $74,537
Option
Common Stock 2,818 N/A N/A
Option
Restricted Stock Units 2,818 N/A N/A
Sale
Common Stock 212 N/A N/A
Option
Common Stock 707 N/A N/A
Option
Restricted Stock Units 707 N/A N/A
Option
Common Stock 707 N/A N/A
Option
Restricted Stock Units 707 N/A N/A
Sale
Common Stock 996 $92.59 $92,219
Option
Restricted Stock Units 2,818 N/A N/A
Option
Common Stock 2,818 N/A N/A
Sale
Common Stock 70,000 $77.75 $5,442,290
Sale
Common Stock 90,000 $77.34 $6,960,600
Sale
Common Stock 90,000 $81.82 $7,364,070
Sale
Common Stock 108 $73.45 $7,933
Option
Restricted Stock Unit 307 N/A N/A
Option
Common Stock 307 N/A N/A
Sale
Common Stock 70,000 $72.63 $5,084,030
Sale
Common Stock 90,000 $71.84 $6,465,420
Sale
Common Stock 90,000 $70.82 $6,373,710
Sale
Common Stock 141 $63.31 $8,926
Option
Restricted Stock Unit 400 N/A N/A
Option
Common Stock 400 N/A N/A
Sale
Common Stock 1,014 $60.77 $61,622
Option
Restricted Stock Unit 2,819 N/A N/A
Option
Common Stock 2,819 N/A N/A
Sale
Common Stock 108 $45.98 $4,966
Option
Common Stock 307 N/A N/A
Option
Restricted Stock Unit 307 N/A N/A
Sale
Common Stock 142 $45.51 $6,463
Option
Restricted Stock Unit 400 N/A N/A
Option
Common Stock 400 N/A N/A
Sale
Common Stock 976 N/A N/A
Option
Common Stock 2,818 N/A N/A
Option
Restricted Stock Unit 2,818 N/A N/A
Option
Common Stock 307 N/A N/A
Option
Restricted Stock Unit 307 N/A N/A
Sale
Common Stock 579 $24.09 $13,946
Option
Common Stock 1,600 N/A N/A
Option
Restricted Stock Unit 1,600 N/A N/A
Sale
Common Stock 1,107 $33.36 $36,930
Option
Common Stock 2,818 N/A N/A
Option
Restricted Stock Unit 2,818 N/A N/A
Sale
Common Stock 127 N/A N/A
Option
Restricted Stock Unit 307 N/A N/A
Option
Common Stock 307 N/A N/A
Sale
Common Stock 16,856 $36.3 $611,940
Sale
Common Stock 33,333 $37.48 $1,249,454
Sale
Common Stock 33,333 $37.81 $1,260,454
Sale
Common Stock 1,409 $36.13 $50,909
Option
Common Stock 2,818 N/A N/A
Option
Restricted Stock Unit 2,818 N/A N/A
Sale
Common Stock 148 $38.2 $5,653
Option
Restricted Stock Unit 307 N/A N/A
Option
Common Stock 307 N/A N/A
Sale
Common Stock 1,417 $29.5 $41,796
Option
Common Stock 2,818 N/A N/A
Option
Restricted Stock Unit 2,818 N/A N/A
Sale
Common Stock 154 $25.84 $3,979
Option
Common Stock 306 N/A N/A
Option
Restricted Stock Unit 306 N/A N/A
Sale
Common Stock 1,418 $24.79 $35,154
Option
Restricted Stock Unit 2,818 N/A N/A
Option
Common Stock 2,818 N/A N/A
Sale
Common Stock 614 $20.25 $12,434
Option
Common Stock 1,227 N/A N/A
Option
Restricted Stock Unit 1,227 N/A N/A
Sale
Common Stock 5,672 $16 $90,769
Option
Common Stock 11,272 N/A N/A
Option
Restricted Stock Unit 11,272 N/A N/A
Option
Stock Option (Right to Buy) 324,205 $1.14 $369,918
Option
Common Stock 665,237 $0.85 $564,121
Sale
Common Stock 81,099 $23.37 $1,895,527
Sale
Common Stock 139,089 $24.84 $3,455,388
Sale
Common Stock 149,910 $25.07 $3,758,244
Sale
Common Stock 35,845 $23.98 $859,456
Sale
Common Stock 73,173 $24.14 $1,766,250
Sale
Common Stock 61,819 $24 $1,483,841
Sale
Common Stock 77,009 $23.75 $1,828,964
Sale
Common Stock 62,283 $24.3 $1,513,228
Sale
Common Stock 67,651 $24.38 $1,649,399
Sale
Common Stock 121,765 $24.28 $2,956,819
Sale
Common Stock 164,473 $24.8 $4,079,095
Sale
Common Stock 53,826 $24.87 $1,338,706
Sale
Common Stock 185,163 $25.36 $4,695,919
Sale
Common Stock 14,021 N/A N/A
Sale
Common Stock 3,400 $12.02 $40,851
Sale
Common Stock 36,507 $12.01 $438,559
Sale
Common Stock 16,165 $12.01 $194,093
Sale
Common Stock 31,731 $12.04 $382,073
Sale
Common Stock 30,408 $12.14 $369,123
Sale
Common Stock 84,617 $12.79 $1,082,505
Sale
Common Stock 61,861 $12.23 $756,251
Sale
Common Stock 43,031 $12.02 $517,405
Sale
Common Stock 732,831 $11.94 $8,750,002
Option
Common Stock 180,439 N/A N/A
Option
Stock Option (right to buy) 180,439 N/A N/A
Sale
Common Stock 2,570 $10.06 $25,841
Sale
Common Stock 52,113 $10.39 $541,350
Sale
Common Stock 59,395 $10.73 $637,308
Sale
Common Stock 52,118 $10.95 $570,432
Sale
Common Stock 83,804 $10.86 $910,111

Natera key executives

Natera, Inc. executives and other stock owners filed with the SEC: